Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court
Pharmaceutical Technology
FEBRUARY 22, 2023
Both drugs come with a high price tag. While the Supreme Court is unpredictable, Amgen has a chance here, says Jorge Contreras, director of the University of Utah’s Program on Intellectual Property and Technology Law. Several intellectual property lawyers have filed their own briefs in support of Sanofi.
104 
Let's personalize your content